Amanda Alleyn, MD
Obstetrics & Gynecology · Lafayette, LANPI 1205077278
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (56.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 69.9% of it on its own, with 38 other manufacturers making up the rest. Reporting peaked in 2022 at $9,561 and has fallen 93.5% since, to $617 in 2025. Among obstetrics & gynecology clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 270 payments — averaging $56.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$11K
- AbbVie$538
- Pfizer$379
- Exeltis, USA Inc.$342
- Sumitomo Pharma America, Inc.$320
- Astellas Pharma US Inc$273
- plus $3K from 33 others
What the payments were for
- Travel & lodging$1,92513%
- Food & beverage$4,74631%
- Education$8,63856%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 23 | $10,695 |
| AbbVie(2 entities) | 30 | $538 |
| Pfizer | 22 | $379 |
| Exeltis, USA Inc. | 20 | $342 |
| Sumitomo Pharma America, Inc. | 17 | $320 |
| Astellas Pharma US Inc | 12 | $273 |
| Johnson & Johnson | 10 | $269 |
| Avion Pharmaceuticals | 16 | $243 |
| Mayne Pharma Commercial LLC | 12 | $230 |
| Coopersurgical, Inc. | 10 | $200 |
| Organon | 11 | $174 |
| AMAG Pharmaceuticals, Inc. | 4 | $153 |
| Bayer | 9 | $152 |
| Hologic Sales And Service, LLC | 7 | $141 |
| Myovant Sciences Inc. | 8 | $133 |
| Evofem Biosciences, Inc. | 6 | $116 |
| Lupin Inc. | 7 | $113 |
| Biom'up France SAS | 2 | $86 |
| Merck | 5 | $77 |
| Pacira Pharmaceuticals Incorporated | 3 | $74 |
| Scynexis, Inc. | 4 | $66 |
| Therapeuticsmd, Inc. | 3 | $52 |
| Millicent US Inc | 2 | $43 |
| Amgen | 3 | $42 |
| Medicem Inc. | 3 | $41 |
| Sage Therapeutics, LLC | 2 | $40 |
| Vertical Pharmaceuticals, LLC | 3 | $40 |
| Davol Inc. | 1 | $37 |
| Shield Therapeutics Inc | 2 | $34 |
| Minerva Surgical, Inc | 2 | $30 |
| Dexcom, Inc. | 1 | $28 |
| Currax Pharmaceuticals LLC | 2 | $27 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Duchesnay USA Incorporated | 2 | $24 |
| Mylan Pharmaceuticals Inc. | 1 | $21 |
| Medtronic | 1 | $14 |
| Meditrina | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Ferring Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAVINCI XI$8,500
- Da Vinci Surgical System$1,881
- INTRAROSA$115
How this compares
$15,310 in reported general payments places this provider in the 95th percentile of 608 obstetrics & gynecology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremproEstrogen,con/M-Progest Acet | 14 | $3,211 |
| Medroxyprogesterone Acetate | 18 | $216 |
| Oxybutynin Chloride ErOxybutynin Chloride | 14 | $107 |
| Norgestimate-Ethinyl Estradiol | 11 | $95 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPrempro | $379 | $3,21114 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 608 obstetrics & gynecology providers in Louisiana.
Other obstetrics & gynecology in Lafayette
- Russell PhelpsLafayette$31K
- Rachelle MeauxLafayette$31K
- Jennifer PuglieseLafayette$14K
- Nicole HarperLafayette$13K
- Mika KingLafayette$9K
- Francis CardinaleLafayette$9K
- John VoltzLafayette$7K
- Charles PadgettLafayette$6K
- Veronica GillispieNew Orleans$117K
- Rachel Bezdekla Place$105K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.